Wealth Enhancement Advisory Services LLC Acquires Shares of 13,858 Inogen, Inc (NASDAQ:INGN)

Wealth Enhancement Advisory Services LLC acquired a new stake in Inogen, Inc (NASDAQ:INGN) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 13,858 shares of the medical technology company’s stock, valued at approximately $99,000. Wealth Enhancement Advisory Services LLC owned approximately 0.05% of Inogen at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AlphaQuest LLC acquired a new stake in Inogen in the 4th quarter valued at about $43,000. GAMMA Investing LLC increased its position in Inogen by 5,738.9% in the 1st quarter. GAMMA Investing LLC now owns 5,547 shares of the medical technology company’s stock valued at $400,000 after acquiring an additional 5,452 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Inogen in the 4th quarter valued at about $56,000. Integrated Quantitative Investments LLC bought a new position in shares of Inogen in the 4th quarter valued at about $92,000. Finally, Intech Investment Management LLC bought a new position in shares of Inogen in the 4th quarter valued at about $94,000. Institutional investors and hedge funds own 89.94% of the company’s stock.

Wall Street Analysts Forecast Growth

INGN has been the topic of several recent research reports. Stifel Nicolaus reduced their target price on shares of Inogen from $10.00 to $7.00 and set a “hold” rating on the stock in a research note on Thursday, May 8th. B. Riley initiated coverage on shares of Inogen in a research note on Monday, June 16th. They issued a “buy” rating and a $14.00 target price on the stock. Finally, Needham & Company LLC raised shares of Inogen from a “hold” rating to a “moderate buy” rating and set a $12.00 target price on the stock in a research note on Thursday, May 22nd.

Inogen Price Performance

Inogen stock opened at $7.31 on Friday. The company’s 50 day simple moving average is $6.67 and its 200 day simple moving average is $8.05. Inogen, Inc has a fifty-two week low of $5.70 and a fifty-two week high of $13.33. The firm has a market capitalization of $196.57 million, a price-to-earnings ratio of -6.36 and a beta of 1.66.

Inogen (NASDAQ:INGN) last released its quarterly earnings data on Wednesday, May 7th. The medical technology company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.52) by $0.27. Inogen had a negative net margin of 8.08% and a negative return on equity of 14.76%. The business had revenue of $82.28 million for the quarter, compared to analyst estimates of $79.57 million. As a group, analysts predict that Inogen, Inc will post -1.73 EPS for the current fiscal year.

About Inogen

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.